Cargando…

The Role of decision-analytic modelling in German health technology assessments

BACKGROUND: Decision-analytic modelling (DAM) has become a widespread method in health technology assessments (HTA), but the extent to which modelling is used differs among international HTA institutions. In Germany, the use of DAM is optional within HTAs of the German Institute of Medical Documenta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuhlmann, Alexander, Treskova, Marina, Braun, Sebastian, Graf von der Schulenburg, J-Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385016/ https://www.ncbi.nlm.nih.gov/pubmed/25853005 http://dx.doi.org/10.1186/s13561-014-0039-x

Ejemplares similares

Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system
por: Kuhlmann, Alexander, et al.
Publicado: (2013)

Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines
por: Treskova, Marina, et al.
Publicado: (2016)

The German plan for rare diseases: a development in progress
por: Graf von der Schulenburg, Johann Mathias
Publicado: (2010)

German Value Set for the EQ-5D-5L
por: Ludwig, Kristina, et al.
Publicado: (2018)

Greetings from the Editors
por: Graf von der Schulenburg, J-Matthias, et al.
Publicado: (2011)

Valuation of the EQ-5D-5L with composite time trade-off for the German population – an exploratory study
por: Ludwig, Kristina, et al.
Publicado: (2017)

Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
por: Jönsson, Bengt, et al.
Publicado: (2018)

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany
por: Kuhlmann, Alexander, et al.
Publicado: (2012)

Note from the editor, January 2021
por: von der Schulenburg, J.-Matthias Graf, et al.
Publicado: (2021)

Promoting vaccinations - an analysis of measures taken by German statutory health insurers
por: Damm, Kathrin, et al.
Publicado: (2011)

COVID-19: not the time for health economists? A plea for more proactive health economic involvement
por: Schulenburg, J.-Matthias Graf von der
Publicado: (2021)

Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system
por: Siebert, Uwe
Publicado: (2005)

Benefit assessment in Germany: implications for price discounts
por: Theidel, Ulrike, et al.
Publicado: (2016)

Applying the Analytic Hierarchy Process in healthcare research: A systematic literature review and evaluation of reporting
por: Schmidt, Katharina, et al.
Publicado: (2015)

Comparison of different approaches applied in Analytic Hierarchy Process – an example of information needs of patients with rare diseases
por: Pauer, Frédéric, et al.
Publicado: (2016)

Age- and gender-based comorbidity categories in general practitioner and pulmonology patients with COPD
por: Kim-Dorner, Su-Jong, et al.
Publicado: (2022)

Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data
por: Treskova, Marina, et al.
Publicado: (2021)

Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review
por: Babac, Ana, et al.
Publicado: (2019)

Occurrence of Antimicrobial Resistance in the Environment in Germany, Austria, and Switzerland: A Narrative Review of Existing Evidence
por: Treskova, Marina, et al.
Publicado: (2022)

Shaping an Effective Health Information Website on Rare Diseases Using a Group Decision-Making Tool: Inclusion of the Perspectives of Patients, Their Family Members, and Physicians
por: Babac, Ana, et al.
Publicado: (2017)

Integrating patient perspectives in medical decision-making: a qualitative interview study examining potentials within the rare disease information exchange process in practice
por: Babac, Ana, et al.
Publicado: (2019)

Genome sequencing: a systematic review of health economic evidence
por: Frank, Martin, et al.
Publicado: (2013)

Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting
por: Treskova, Marina, et al.
Publicado: (2017)

Decision-analytic modeling for early health technology assessment of medical devices – a scoping review
por: Conrads-Frank, Annette, et al.
Publicado: (2022)

Rare Diseases on the Internet: An Assessment of the Quality of Online Information
por: Pauer, Frédéric, et al.
Publicado: (2017)

Regional differences of outpatient physician supply as a theoretical economic and empirical generalized linear model
por: Scholz, Stefan, et al.
Publicado: (2015)

Dividend policy issues in the European pharmaceutical industry: new empirical evidence
por: Basse, Tobias, et al.
Publicado: (2022)

Population with an increased risk of severe COVID-19 in Germany. Analyses from GEDA 2019/2020-EHIS
por: Rommel, Alexander, et al.
Publicado: (2021)

Use of a decision-analytic model in a health technology assessment: beyond measuring value for money
por: Kim, Sun-Young
Publicado: (2013)

Health Technology Assessment of laparoscopic compared to conventional surgery with and without mesh for incisional hernia repair regarding safety, efficacy and cost-effectiveness
por: Friedrich, Meik, et al.
Publicado: (2008)

The German Health Update GEDA 2014/2015-EHIS – possibilities for international and regional assessment
por: von der Lippe, Elena, et al.
Publicado: (2018)

Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks
por: Schmidt, Katharina, et al.
Publicado: (2016)

Nachhaltige Vergütung der B‑Zentren für Seltene Erkrankungen in Deutschland – Status quo und Lösungsansätze
por: Litzkendorf, Svenja, et al.
Publicado: (2022)

Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis -
por: Klora, Mike, et al.
Publicado: (2015)

Medical and health economic assessment of radiosurgery for the treatment of brain metastasis
por: Müller-Riemenschneider, Falk, et al.
Publicado: (2009)

Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysis
por: Aumann, I., et al.
Publicado: (2016)

The role of absorptive capacity in the use of digital marketing analytics for effective marketing decisions
por: Proença, Marina, et al.
Publicado: (2023)

Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation
por: Ruof, Jörg, et al.
Publicado: (2013)

Generating evidence to inform health technology assessment of treatments for SLE: a systematic review of decision-analytic model-based economic evaluations
por: Gavan, Sean, et al.
Publicado: (2020)

Treatment‐related experiences and preferences of patients with lung cancer: a qualitative analysis
por: Aumann, Ines, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s7j2uvd5v2pf6lra4tqv7ks1m4